FEN-1 (B-4)...
Synphilin 1 Immunogen: Synthetic peptide corresponding to residues S(829) L E L N G E K D K D K G R T L Q R T(847) of human Synphilin 1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
KAI 1 (G-2)...
Anti-Mouse Valpha 2 TCR, Purified (Clone B20.1) (rat IgG2a)...
Biology Products:Mouse Anti-FEN-1 Monoclonal Antibody, Unconjugated, Clone B-4 from Santa Cruz Biotechnology, Inc.Goat Anti-Human Synphilin 1 Antibody, Unconjugated from ABR-Affinity BioReagentsMouse Anti-Human KAI 1 Monoclonal Antibody, Unconjugated, Clone G-2 from Santa Cruz Biotechnology, Inc.Rat Anti-Mouse TCR, Va 2 Monoclonal Antibody, Unconjugated, Clone B20.1 from CEDARLANE Laboratories Limited ... morbidity and mortality worldwide. Several interacting environmental, biochemical, ... While some of the genes involved in the ... to be discovered. During the last few decades, ... linkage and association methods, and with more targeted ...
... new blood test that can give an early diagnosis ... disease could be launched this summer, reports Marina Murphy ... proteomics company, Power3 Medical Products, said it plans to ... diagnostic test for neurodegenerative diseases on the market, in ...
... rapid weight gain believed to afflict many new college students when ... urban legend: a cautionary tale often told but not well substantiated. ... - located in one of the states with the highest prevalence ... only 1.9 pounds during the first semester, with women gaining slightly ...
Other Biology News:Genetic variants of USF1 are associated with the increased risk for cardiovascular disease 2First diagnostic test for Alzheimer's and Parkinson's disease on the horizon 2Fabled 'Freshman 15' pound gain more often only 5, report researchers 2(Date:12/16/2009)... -- Capitalizing on the continued strong ... active venture capital market, leaders from BioCrossroads, Eli ... Indiana University, Purdue University, the University of Notre ... today announced the establishment of the INext Fund, ... ,, Organized through BioCrossroads, Indiana,s initiative to grow, ...
(Date:12/16/2009)... culture supplement? InVitria has what scientists have been asking for! ... improves the growth and productivity of CHO cells. Developed for ... animal free, well defined and consistent recombinant CHO supplement. ... ... 16, 2009 -- Scientists working with CHO cells can now ...
(Date:12/15/2009)... (JBEI), one of three Department of Energy (DOE) bio-energy ... to protect its valuable intellectual property. , ... ... 15, 2009 -- Surety, LLC , the leading ... announced that the Joint BioEnergy Institute (JBEI), one of ...
(Date:12/15/2009)... CHARLOTTESVILLE, Va., Dec. 15 AstraZeneca ... University of Virginia (UVa) in Charlottesville, today ... strategic research collaboration to enhance development of ... (CAD) with a secondary focus on peripheral ... ) ,, The collaborative preclinical research ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Biology NavigationMedical Navigation